Antibiotic Compounds in Phase II/III Trials to Be Featured at Antibacterial Drug Discovery & Development Conference on March 13-14, 2000, in Princeton, NJ
20.12.1999, 10:40
PRINCETON, N.J. (PROTEXT) - Late-stage antibacterial compoundsin clinic will be featured at the "5th InternationalAntibacterial Drug Discovery & Development Summit" on March 13-14, 2000 at the Hyatt Regency Hotel in Princeton, NJ, announcesStrategic Research Institute, the sponsor. The international conference will feature promising clinicalagents including oxazolidinones, glycylcyclines, beta-lactamases,carbapenems, quinolones, ketolides, everinomycins, andlipopeptides. Also featured in the broader agenda will be novelantibacterial discovery approaches such as efflux pumps, genomictargets, pharmacokinetic pharmacodynamic modeling, glycopeptidesand beta-lactamase inhibitors. Resistance to antibiotic chemotherapies, particularlysurveillance efforts to benchmark the growing problem, and paperson streptococcus pneumoniae and staphylococcus aureus resistancedetected in quinolones, ketolides and macrolides, will bediscussed. Presenters from the pharmaceutical industry include the RWJohnson PRI, Wyeth Ayerst, Hoechst Marion Roussel, Abbott Labs,Schering Plough, Intrabiotics, Cubist, Bristol-Myers Squibb,Pharmacia & Upjohn, Pfizer, Merck and SmithKline Beecham, andMicrocide, among others. Dr. George Drusano of the Albany Medical College, theorganizers are pleased to announce, shall present the keynoteaddress entitled "Pharmacokinetic/Pharmacodynamic Alternatives inAntimicrobial Clinical Trials. To request the agenda and/or register, please contact CamilleCoward of Strategic Research Institute, atccoward@srinstitute.com (include company/university and mailingaddress) or by phone at (USA) 212-967-0095, x255. Contact MarkAlexay for information about sponsorship and exhibition at (USA)212-967-0095, x251 or at malexay@srinstitute.com . ots OriginalText Service: Strategic Research Institute L.P. Internet:http://www.newsaktuell.de Contact: Camille Coward, (USA) 212-967-0095 ext. 255, or ccoward@srinstitute.com, or Mark Alexay,Sponsorship and Exhibition, (USA) 212-967-0095, ext. 251, ormalexay@hotmail.com, both of the Strategic Research InstituteL.P. Web site: http://www.srinstitute.com
Subscribers please note that material bearing the slug"PROTEXT" is not part of CTK's news service and is not to bepublished under the "CTK" slug. Protext is a commercial serviceproviding distribution of press releases from clients, who areidentified in the text of Protext reports and who bear fullresponsibility for their contents.
PROTEXT